-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$51.50498.84% Upside
Emergent BioSolutions Inc. Frequently Asked Questions
-
What analysts cover Emergent BioSolutions Inc.?
Emergent BioSolutions Inc. has been rated by research analysts at Wells Fargo, Chardan Capital in the past 90 days.